{"id":186460,"date":"2010-01-15T17:18:36","date_gmt":"2010-01-15T22:18:36","guid":{"rendered":"http:\/\/blogs.wsj.com\/health\/2010\/01\/15\/antipsychotics-nursing-homes-and-the-feds-case-against-jj\/"},"modified":"2010-01-15T17:18:36","modified_gmt":"2010-01-15T22:18:36","slug":"antipsychotics-nursing-homes-and-the-feds%e2%80%99-case-against-jj","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/186460","title":{"rendered":"Antipsychotics, Nursing Homes and the Feds\u2019 Case Against J&J"},"content":{"rendered":"

\"Risperdal\"The feds say<\/a> J&J paid kickbacks to a big nursing-home pharmacy company to get the company to prescribe more of its drugs, including the antipsychotic Risperdal. <\/p>\n

The allegation isn’t a huge surprise: The pharmacy company, Omnicare, paid $98 million last year to settle allegations that it had solicited and received kickbacks from J&J in exchange recommending the company’s antipsychotic drug Risperdal.<\/p>\n

J&J told the WSJ<\/a> today that “airing the facts will confirm that our conduct, including rebating programs like those the government now challenges, was lawful and appropriate.”<\/p>\n

As we noted<\/a> when the Omnicare settlement was announced, the story of nursing-home patients getting antipsychotics is long and thorny. <\/p>\n

Risperdal, like many other psychotics, raises the risk of death in patients with psychosis that stems from dementia, and isn’t approved to treat this form of psychosis. Nevertheless, the drugs have been widely prescribed to nursing-home patients with dementia, as the WSJ reported<\/a> back in 2007.<\/p>\n

J&J isn’t the only company that’s been accused of wrongdoing in this market. Eli Lilly used<\/a> a “5 at 5″ slogan to promote the antipsychotic Zyprexa’s side effect of sedation to nursing-home doctors, according to the Department of Justice: 5 milligrams of the drug at 5 p.m. would help patients sleep.<\/p>\n

Eli Lilly paid a $1.42 billion settlement and pleaded guilty to a misdemeanor as part of a broad DOJ inquiry into the way the company marketed Zyprexa.<\/p>\n

Photo: Bloomberg News<\/em><\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

\n<\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a>\n<\/div>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

The feds say J&J paid kickbacks to a big nursing-home pharmacy company to get the company to prescribe more of its drugs, including the antipsychotic Risperdal. The allegation isn’t a huge surprise: The pharmacy company, Omnicare, paid $98 million last year to settle allegations that it had solicited and received kickbacks from J&J in exchange […]<\/p>\n","protected":false},"author":650,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-186460","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/186460","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/650"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=186460"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/186460\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=186460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=186460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=186460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}